{
    "clinical_study": {
        "@rank": "100971", 
        "arm_group": [
            {
                "arm_group_label": "T2380", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Mydriatic and anesthetic", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the efficacy and safety assessment of T2380 for\n      mydriasis and anaesthesia in phacoemulsification cataract surgery versus reference group\n      (topical mydriatics and anaesthetic) 2X246 patients."
        }, 
        "brief_title": "Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Cataract", 
        "condition_browse": {
            "mesh_term": "Cataract"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed and dated informed consent\n\n          -  Male or female aged from 40 to 88 years old\n\n          -  Scheduled to undergo unilateral cataract surgery\n\n        Exclusion criteria:\n\n          -  Combined surgery\n\n          -  Previous intraocular surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "88 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "555", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02101359", 
            "org_study_id": "LT2380-PIII-05/10"
        }, 
        "intervention": [
            {
                "arm_group_label": "T2380", 
                "description": "Intracameral administration during surgery", 
                "intervention_name": "T2380", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Mydriatic and anesthetic", 
                "description": "Topical treatments used the day of surgery", 
                "intervention_name": "Mydriatics and anesthetic", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Mydriatics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Clermont- Ferrand", 
                    "country": "France", 
                    "zip": "63430"
                }, 
                "name": "Laboratoires Thea"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery Versus Reference Group (Topical Mydriatics and Anaesthetic)", 
        "overall_official": {
            "last_name": "Joseph COLIN", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Italy: Ethics Committee", 
                "Spain: Ministry of Health", 
                "Portugal: National Pharmacy and Medicines Institute"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The primary efficacy variable is response based on the realisation of the capsulorhexis.", 
            "safety_issue": "No", 
            "time_frame": "Day 0"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02101359"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Pupil size will be measure at specific times during cataract surgery", 
                "measure": "Pupil size measured", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "description": "Patient's discomfort will be evaluated during cataract surgery", 
                "measure": "Assessment of patient's discomfort during cataract surgery", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "description": "Delay between instillation / injection and capsulorhexis", 
                "measure": "Time necessary for obtaining sufficient mydriasis", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }
        ], 
        "source": "Laboratoires Thea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Laboratoires Thea", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}